(Q46263820)

20 December 2017

title

EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas (English)

1 reference

20 December 2017

1 reference

Yan Liu

1

1 reference

20 December 2017

Mei Lin Xu

2

1 reference

20 December 2017

Hao Hao Zhong

3

1 reference

20 December 2017

Wan Jie Heng

4

1 reference

20 December 2017

Bing Quan Wu

5

1 reference

20 December 2017

publication date

5 November 2008

1 reference

20 December 2017

Pathology Oncology Research

published in

1 reference

20 December 2017

volume

14

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

373-379

1 reference

20 December 2017

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12253-008-9113-1

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib

21 January 2018

1 reference

12 December 2020

Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy

1 reference

12 December 2020

Mutational analysis of the tyrosine kinome in colorectal cancers

1 reference

12 December 2020

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

1 reference

12 December 2020

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

1 reference

12 December 2020

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

1 reference

12 December 2020

Predictors of the response to gefitinib in refractory non-small cell lung cancer

1 reference

12 December 2020

Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung

1 reference

12 December 2020

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer]

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer

1 reference

12 December 2020

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer

1 reference

12 December 2020

Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.

1 reference

12 December 2020

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

12 December 2020

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

1 reference

12 December 2020

Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know

1 reference

12 December 2020

10.1007/S12253-008-9113-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017